Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide

Introduction: Semaglutide is a glucagon-like peptide-1 receptor agonist that treats type 2 diabetes mellitus and can be used as an adjunct for weight loss when combined with exercise and diet. Here we report a case of a bilateral, incongruent central visual scotoma under scotopic conditions in a boa...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Bracha, William Johnson, Sabrina Chu, James Davison
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993624001312
Tags: Add Tag
No Tags, Be the first to tag this record!